T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2-Reference-Cited by-同舟云学术

T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2

Published:1986-12 Issue:2 Volume:103 Page:476-480
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Malkovský Miroslav,Brenner Malcolm K.,Hunt Ruth,Rastan Sohaila,Dore Caroline,Brown Sheila,North Margaret E.,Asherson Geoffrey L.,Prentice H.Grant,Medawar Peter B.

Publisher

Elsevier BV

Subject

Immunology

Reference24 articles.

1. IMMUNOLOGICAL MECHANISMS OF GRAFT-VERSUS-HOST DISEASE IN MAN

2. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors

3. Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2

4. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medawar and the immunological paradox of pregnancy: in context;Oxford Open Immunology;2020-12-14

2. Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease;Therapeutic Advances in Hematology;2020-01

3. The Pathophysiology of Graft-versus-Host Disease;Thomas’ Hematopoietic Cell Transplantation;2016-01-01

4. Is Human Cell Therapy Research Caught in a Mousetrap?;Molecular Therapy;2011-02

5. Study of Relieving Graft-versus-Host Disease by Blocking CD137-CD137 Ligand Costimulatory Pathway in Vitro;International Journal of Hematology;2007-07-01